Summary of Significant Accounting Policies (Details)
|
|
|
|
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Aug. 29, 2025
USD ($)
|
Aug. 26, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Mar. 31, 2026
USD ($)
|
Sep. 30, 2025
USD ($)
$ / shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Jun. 30, 2025
USD ($)
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
|
Feb. 28, 2026
$ / shares
shares
|
Feb. 26, 2026
shares
|
Feb. 18, 2026 |
Dec. 12, 2025
USD ($)
|
Jun. 04, 2025
$ / shares
shares
|
Mar. 31, 2025
USD ($)
|
Feb. 26, 2025
USD ($)
|
Dec. 31, 2023
USD ($)
|
Feb. 09, 2023 |
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Impairment charges |
|
|
|
|
|
|
|
|
|
|
$ 111,033
|
|
|
|
|
|
|
|
|
|
| Equity method investment |
|
|
|
|
|
|
|
|
|
|
10,636,544
|
|
|
|
|
|
|
|
|
|
| Exceed federally-insured limits |
250,000
|
|
|
$ 250,000
|
|
|
|
$ 250,000
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
| Federally insured limits |
0
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Deferred offering costs |
84,652
|
|
|
|
|
|
|
|
|
84,652
|
|
|
|
|
|
|
|
|
|
|
| Impairment |
|
|
|
|
|
|
|
|
|
|
259,579
|
|
|
|
|
|
|
|
|
|
| Carrying value equity method investment |
|
|
|
|
|
|
|
|
|
1,069,000
|
|
|
|
|
|
|
|
|
|
|
| Redemption aggregate cash amount |
|
|
|
|
|
|
|
|
|
1,745,000
|
|
|
|
|
|
|
|
|
|
|
| Payment of equity investment |
|
|
|
|
|
|
|
|
|
95,000
|
|
|
|
|
|
|
|
|
|
|
| Regular payments on equity investments |
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
| Reserve for credit loss |
0
|
|
|
|
|
|
$ 1,650,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reserve for credit loss |
|
|
|
|
|
|
1,650,000
|
|
$ 1,650,000
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate amount |
|
$ 1,122,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit loss recovery |
|
|
|
|
|
$ 1,650,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.51
|
|
|
|
|
|
|
|
|
| Proceeds from stock subscription liability |
|
|
|
|
|
|
|
|
|
150,000
|
|
|
|
|
|
|
|
|
|
|
| Advertising and marketing costs |
|
|
|
105,271
|
|
|
$ 322,552
|
$ 315,117
|
393,702
|
843,497
|
$ 237,671
|
|
|
|
|
|
|
|
|
|
| Dilutive securities |
|
|
|
|
|
|
|
|
$ 162,473
|
$ 162,473
|
|
|
|
|
|
|
|
|
|
|
| Common stock, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
$ 1
|
$ 1
|
|
$ 1
|
$ 11.25
|
|
|
|
|
|
|
|
|
|
| Percentage of purchase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40.00%
|
|
40.00%
|
| Reverse stock split |
|
|
|
|
|
|
|
|
|
1-for-15
|
|
|
|
|
|
|
|
|
|
|
| Cash equivalent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Federally-insured limits |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of fair value |
|
|
|
|
|
|
|
9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid-in capital of capital transaction |
|
|
|
|
$ 1,861,266
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds of sale of subsidiary |
|
|
|
|
|
|
|
9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Advance to sale of subsidiary |
|
|
|
3,158,078
|
|
|
|
3,158,078
|
|
|
|
|
|
|
|
|
|
|
|
|
| Note payable |
|
|
|
1,188,700
|
|
|
|
1,188,700
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paying off due to related party |
|
|
|
|
|
|
|
41,922
|
|
|
|
|
|
|
|
|
|
|
|
|
| Excess of its carrying value |
|
|
|
|
|
|
|
7,138,734
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share subscription liability |
$ 150,000
|
|
|
$ 150,000
|
|
|
|
$ 150,000
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants (in Shares) | shares |
|
|
|
3,491,000
|
|
|
150,000
|
3,491,000
|
150,000
|
|
|
|
|
|
|
|
|
|
|
|
| CODM description |
|
|
|
|
|
|
|
The
Company’s Chief Executive Officer is its CODM. The Company reports operational data to its CODM at the segment level, which he
uses to evaluate performance and allocate resources based on income from equity method investment – Lab Services MSO and AI generated
publishing operating income.
|
|
During the year ended December 31, 2025, the management reporting structure was composed of two strategic business units, mainly
organized by services, led by the Company’s Chief Executive Officer, who is its CODM. Using the accounting guidance on segment
reporting, the Company determined that its two operating segments were aligned with its two reportable segments corresponding to its
strategic business units.
|
|
|
|
|
|
|
|
|
|
|
| Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] |
|
|
|
|
|
|
|
Chief Executive Officer
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
| Developed technology and Trade Name [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Estimated useful life |
1 year
|
|
|
1 year
|
|
|
|
1 year
|
|
1 year
|
|
|
|
|
|
|
|
|
|
|
| Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding (in Shares) | shares |
504,300
|
|
|
3,491,000
|
|
|
|
3,491,000
|
|
504,300
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares subscribed (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,643
|
|
|
|
|
| Per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.53
|
|
|
|
|
| Warrants outstanding (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
1,733,571
|
|
|
|
|
|
|
|
|
| Additional paid-in capital of capital transaction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lab Services MSO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment |
|
|
|
|
|
|
|
|
|
|
$ 10,636,544
|
|
|
|
|
|
|
|
$ 12,095,020
|
|
| Equity interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40.00%
|
|
|
| Carrying value equity method investment |
|
|
|
|
|
|
|
|
|
11,029,221
|
|
|
|
|
|
|
|
|
|
|
| Carrying value of the extinguished |
|
|
|
|
|
|
|
|
|
632,916
|
|
|
|
|
|
|
|
|
|
|
| Lab Services MSO [Member] | Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Carrying value equity method investment |
|
|
|
|
|
|
|
|
|
$ 13,377,916
|
|
|
|
|
|
|
|
|
|
|
| Dr Yu Zhou [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest rate |
40.00%
|
|
|
|
|
|
|
|
|
40.00%
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Common Stock [Member] | Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0.5099
|
|
|
|
|
|
|
|
| Subscription Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from stock subscription liability |
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
| Share subscription liability |
|
|
|
$ 150,000
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mr. Lu [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of membership interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
| Mr. Lu [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of membership interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
| RMB [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency exchange rate |
7.1889
|
|
|
|
|
|
|
|
|
7.1889
|
7.1889
|
|
|
|
|
|
|
|
|
|
| RMB [Member] | Asset and liability Accounts [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency exchange rate |
6.9964
|
|
|
|
|
|
|
|
|
6.9964
|
7.298
|
|
|
|
|
|
|
|
|
|
| United States [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency exchange rate |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
| United States [Member] | Asset and liability Accounts [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency exchange rate |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
| Laboratory Services MSO, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate amount |
|
600,000
|
$ 1,722,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Attorneys fees |
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest receivable |
|
|
$ 22,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Monthly installment |
|
$ 93,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lab Services MSO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Redemption aggregate cash amount |
|
|
|
|
|
|
|
|
|
$ 11,029,221
|
|
|
|
|
|
|
|
|
|
|
| Laboratory Services MSO, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment |
|
|
|
|
|
|
|
|
|
|
$ 259,579
|
|
|
|
|
|
|
|
|
|
| Related Party [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid-in capital of capital transaction |
|
|
|
|
|
|
|
1,861,266
|
|
|
|
|
|
|
|
|
|
|
|
|
| Wenzhao Lu [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Note payable |
|
|
|
$ 5,800,000
|
|
|
|
$ 5,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Laboratory Equipment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Impairment charges |
|
|
|
|
|
|
|
|
|
111,033
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,000,000
|
|
|
| Carrying value of the extinguished |
|
|
|
|
|
|
|
|
|
$ 2,348,695
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, convertible conversion price (in Dollars per share) | $ / shares |
$ 56.7
|
|
|
|
|
|
|
|
|
$ 56.7
|
|
|
|
|
|
|
|
|
|
|
| Common stock, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 56.7
|
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Lab Services MSO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Carrying value equity method investment |
|
|
|
|
|
|
|
|
|
$ 11,000,000
|
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Lab Services MSO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,000,000
|
|
|
|
| Series A Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, convertible conversion price (in Dollars per share) | $ / shares |
150
|
|
|
|
|
|
|
|
|
$ 150
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, convertible conversion price (in Dollars per share) | $ / shares |
2.41
|
|
|
$ 2.41
|
|
|
|
$ 2.41
|
|
2.41
|
|
|
|
|
|
|
|
|
|
|
| Series D Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,000,000
|
|
|
|
|
|
| Preferred stock, convertible conversion price (in Dollars per share) | $ / shares |
2.41
|
|
|
2.41
|
|
$ 2.41
|
|
2.41
|
|
2.41
|
|
|
|
|
|
|
|
|
|
|
| Series E Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, convertible conversion price (in Dollars per share) | $ / shares |
$ 1.5
|
|
|
$ 1.5
|
|
|
|
$ 1.5
|
|
$ 1.5
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Significant Accounting Policies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares subscribed (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,643
|
|
|
|
|
| Per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.53
|
|
|
|
|